白術內(nèi)酯Ⅰ

分析標準品,HPLC≥98%

Atractylenolide I

CAS號：73069-13-3

分子式：C15H18O2

分子量：230.3

MDL：MFCD09037395

產(chǎn)品介紹

熔點：108-110℃（石油mi-乙酸乙酯）

沸點：405℃ at 760 mmHg

比旋光度：(c, 0.01 in MeOH)+222

外觀：白色針狀結晶

溶解性：DMSO：20mg/ml

儲存條件：2-8℃

注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權*威性，僅供客戶參考交流研究之用。

參考文獻(31篇)

31. [IF=2.5] Ya Gao et al."Atractylenolide-I Ameliorates Motor Deficits and Reduces Inflammation of the Spinal Cord by SIRT1/PGC-1α Pathway in MPTP Subacute Mouse Model of Parkinson’s Disease."Neuropsychiatric Disease and Treatment.

30. [IF=14.3] Xietao Ye et al."Monocyte/Macrophage-Mediated Transport of Dual-Drug ZIF Nanoplatforms Synergized with Programmed Cell Death Protein-1 Inhibitor Against Microsatellite-Stable Colorectal Cancer."Advanced Science.2024 Aug;:2405886

29. [IF=6.7] Yan Sun et al."Zexieyin formula alleviates Alzheimer's disease via post-synaptic CaMKII modulating AMPA receptor: Involved in promoting neurogenesis to strengthen synaptic plasticity in mice hippocampus."PHYTOMEDICINE.2024 Aug;131:155802

28. [IF=7.9] Mengwei Wang et al."Atractylenolide-I Alleviates Hyperglycemia-Induced Heart Developmental Malformations through Direct and Indirect Modulation of the STAT3 Pathway."PHYTOMEDICINE".2024 Jul;129:155698

27. [IF=2] Ying Tang et al."Geographical Origin Traceability of Atractylodes macrocephala Koidz. Using Mass Spectrometry Data Fusion and Ensemble Learning."ANALYTICAL LETTERS.10.1080/00032719.2024.2323074

26. [IF=1.8] Yue Qian et al."Si Miao San relieves hyperuricemia by regulating intestinal flora."BIOMEDICAL CHROMATOGRAPHY.2023 Dec;:e5807

25. [IF=3.4] Jiaxin Yin et al."Comprehensive multicomponent characterization and quality assessment of Xiaoyao Wan by UPLC-Q-Orbitrap-MS, HS-SPME-GC-MS and HS-GC-IMS."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2024 Feb;239:115910

24. [IF=5.2] Zhixing Gu et al."Simultaneous Analysis of Hydrophobic Atractylenolides, Atractylon and Hydrophilic Sugars in Bai-Zhu Using a High-Performance Liquid Chromatography Column Tandem Technique."Foods.2023 Jan;12(21):3931

23. [IF=4.6] Hailong Qiu et al."Geoherbalism Metabolomic Analysis of Atractylodes lancea (Thunb.) DC. by LC-Triple TOF-MS/MS and GC-MS."MOLECULES.2023 Jan;28(16):5974

22. [IF=4.9] Zhang Min et al."Discovery and evaluation of active compounds from Xuanfei Bai du formula against COVID -19 via SARS-CoV-2 Mpro."Chinese Medicine.2023 Dec;18(1):1-14

21. [IF=3.246] Yue Qian et al."A Network Pharmacology Method Combined with Molecular Docking Verification to Explore the Therapeutic Mechanisms Underlying Simiao Pill Herbal Medicine against Hyperuricemia."Biomed Research International.2023;2023:2507683

20. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199

19. [IF=4.759] Gao-Yan Tong et al."Analysis of active compounds and geographical origin discrimination of Atractylodes macrocephala Koidz. by using high performance liquid chromatography-diode array detection fingerprints combined with chemometrics."JOURNAL OF CHROMATOGR

18. [IF=3.205] Jie Tang et al."Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry."J Chromatogr B. 2021 Aug;1179:122827

17. [IF=4.032] Qiu-yue Xiao et al."A network pharmacology-based study on key pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease."Exp Gerontol. 2021 Jul;149:111336

16. [IF=4.36] Xiaoli Zhao et al."Transcriptomic study of the mechanism by which the Kai Yu Zhong Yu recipe improves oocyte quality in a stressed mouse model."J Ethnopharmacol. 2021 Oct;278:114298

15. [IF=4.96] Yangyang Guo et al."Inhibition of proliferation-linked signaling cascades with atractylenolide I reduces myofibroblastic phenotype and renal fibrosis."Biochem Pharmacol. 2021 Jan;183:114344

14. [IF=3.935] Qian Wang et al."Content determination of the major constituents of Yinchenzhufu decoction via ultra high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry."J Pharmaceut Biomed. 2013 Apr;77:88

13.  Wang, Qian, et al. "Content determination of the major constituents of Yinchenzhufu decoction via ultra high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry." Journal of pharmaceutical and biomedical analysis

12.  Wang, Qian, et al. "Content determination of the major constituents of Yinchenzhufu decoction via ultra high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry." Journal of pharmaceutical and biomedical analysis

11.  李琴瑜, 吳衛(wèi)剛, 崔波, et al. 高效液相色譜法結合多元統(tǒng)計分析用于蒼術藥材的質量評價[J]. 藥物分析雜志, 2018, v.38(04):56-66.

10.  陳文婷, 陳陽, 崔波,等. 氣相色譜"一測多評"用于蒼術多成分含量測定的可行性研究[J]. 中國中藥雜志, 2018, 043(003):551-556.

9.  丁逸雪  徐繼校  吳威 等. HPLC法同時測定白術中4種倍半萜[J]. 中成藥  2020  042(004):927-931.

8.  李春花, 李佳佳, 頓佳穎,等. 提取-共沸精餾耦合技術提取白術、桂枝揮發(fā)油工藝優(yōu)化[J]. 中成藥, 2019, 41(05):1132-1135.

7.  歐陽麗敏, 王新宏, 朱思敏,等. 基于AHP-CRITIC法探討英山茅蒼術最*佳采收期[J]. 中成藥, 2020, 042(003):708-713.

6.  李紅英,龍瀾,程新華,李亞杰,黃建民,帥超群.白術藥材中白術內(nèi)酯Ⅰ和白術內(nèi)酯Ⅲ含量的測定[J].湖北民族學院學報(自然科學版),2013,31(02):142-144.

5.  王建成. 白術中白術內(nèi)酯Ⅰ,Ⅱ,Ⅲ提取工藝優(yōu)選[J]. 中國實驗方劑學雜志, 2015.

4.  張東 周其.HPLC法測定白術藥材中白術內(nèi)酯Ⅰ和白術內(nèi)酯Ⅲ含量[J].北方藥學 2017 14(03):1-2.

3.  鄧頌, 王愛萍, 陳曦,等. 黃芪白術湯下調miR-31-5p/STAT3環(huán)路抑制結腸炎相關性結腸癌進程[J]. 中國藥理學通報, 2019, v.35(09):134-139.

2.  沈建濤, 張振凌. 白術炮制品中白術內(nèi)酯Ⅰ、Ⅲ含量隨放置時間變化的研究[J]. 時珍國醫(yī)國藥, 2014, 025(008):1873-1875.

1.  邸思蓉  王雪  王燦燦 等. HPLC法同時測定肝炎康散中四種有效成分及指紋圖譜研究[J]. 沈陽藥科大學學報  2019  36(04):308-314.

從2011年開始我們致力于在生命科學領域、生物醫(yī)學實驗技術及論文潤色服務，協(xié)助客戶各類實驗服務及論文潤色十余年，是客戶您值得信賴的科研合作伙伴!

如果您受時間、試驗條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。

實驗技術服務：